Nuvectis Pharma
NVCT----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Nuvectis Pharma(NVCT) predict that the EBIT is -6.26 M (-12.43%), Beat estimate;the EPS is -0.26 (+3.7%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B12.43%
-0.01B39.71%
+0.00B27.28%
EPSExceed expectations
-0.263.70%
-0.31416.30%
+0.054020.00%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf